Overview

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Status:
NOT_YET_RECRUITING
Trial end date:
2027-01-01
Target enrollment:
Participant gender:
Summary
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Phase:
PHASE1
Details
Lead Sponsor:
Johns Hopkins University
Collaborators:
Rose Hill
Usona Institute
Treatments:
Psilocybin